Donna A. Messner

557 total citations
23 papers, 327 citations indexed

About

Donna A. Messner is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Donna A. Messner has authored 23 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Economics and Econometrics, 7 papers in Public Health, Environmental and Occupational Health and 5 papers in General Health Professions. Recurrent topics in Donna A. Messner's work include Health Systems, Economic Evaluations, Quality of Life (18 papers), Delphi Technique in Research (5 papers) and Pharmaceutical Economics and Policy (5 papers). Donna A. Messner is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (18 papers), Delphi Technique in Research (5 papers) and Pharmaceutical Economics and Policy (5 papers). Donna A. Messner collaborates with scholars based in United States, United Kingdom and Canada. Donna A. Messner's co-authors include Sean Tunis, Rachael Moloney, Elizabeth Clearfield, Michelle Witkop, Glenn F. Pierce, Mark W. Skinner, Alfonso Iorio, Adrian Towse, Ellen Tambor and Penny Mohr and has published in prestigious journals such as JAMA, Journal of Clinical Epidemiology and Clinical Chemistry.

In The Last Decade

Donna A. Messner

23 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donna A. Messner United States	11	102	81	69	58	54	23	327
Emelie Andersson Sweden	11	78 0.8×	41 0.5×	38 0.6×	35 0.6×	23 0.4×	27	442
Eline van Overbeeke Belgium	14	322 3.2×	151 1.9×	85 1.2×	80 1.4×	88 1.6×	26	674
John J. Ko United States	11	102 1.0×	50 0.6×	54 0.8×	21 0.4×	29 0.5×	23	443
Deborah Casso United States	10	56 0.5×	46 0.6×	62 0.9×	20 0.3×	45 0.8×	16	468
Gurvaneet Randhawa United States	14	91 0.9×	77 1.0×	72 1.0×	41 0.7×	226 4.2×	28	597
Joshua Posner United States	11	104 1.0×	29 0.4×	19 0.3×	16 0.3×	54 1.0×	24	326
Andrew R. Wong United States	5	157 1.5×	71 0.9×	163 2.4×	13 0.2×	18 0.3×	9	436
Costel Chirila United States	13	74 0.7×	42 0.5×	23 0.3×	17 0.3×	22 0.4×	35	423
Mark Rubino United States	10	110 1.1×	43 0.5×	44 0.6×	29 0.5×	20 0.4×	12	641
Chi-Hui Fang United States	8	314 3.1×	129 1.6×	54 0.8×	11 0.2×	35 0.6×	13	483

Countries citing papers authored by Donna A. Messner

Since Specialization

Citations

This map shows the geographic impact of Donna A. Messner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna A. Messner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna A. Messner more than expected).

Fields of papers citing papers by Donna A. Messner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna A. Messner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna A. Messner. The network helps show where Donna A. Messner may publish in the future.

Co-authorship network of co-authors of Donna A. Messner

This figure shows the co-authorship network connecting the top 25 collaborators of Donna A. Messner. A scholar is included among the top collaborators of Donna A. Messner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna A. Messner. Donna A. Messner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Messner, Donna A., et al.. (2023). Perception of burden of oral and inhaled corticosteroid adverse effects on asthma-specific quality of life. Annals of Allergy Asthma & Immunology. 131(6). 745–751.e11. 6 indexed citations

Clearfield, Elizabeth, Ellen Tambor, Ellen M. Janssen, & Donna A. Messner. (2020). Increasing the Patient-Centeredness of Health Economics and Outcomes Research Through Patient Engagement in Core Outcome Set Development. Patient. 14(4). 413–420. 11 indexed citations

Moloney, Rachael, Donna A. Messner, & Sean Tunis. (2019). The increasing complexity of the core outcomes landscape. Journal of Clinical Epidemiology. 116. 150–154. 13 indexed citations

Messner, Donna A., Peter V. Rabins, Michael C. Irizarry, et al.. (2019). Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers?. The Journal of Prevention of Alzheimer s Disease. 6(1). 20–26. 4 indexed citations

Clearfield, Elizabeth, et al.. (2019). OP163 Health Technology Assessment Participation And Prioritization In Core Outcome Set Development. International Journal of Technology Assessment in Health Care. 35(S1). 35–35. 1 indexed citations

Iorio, Alfonso, Mark W. Skinner, Elizabeth Clearfield, et al.. (2018). Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project. Haemophilia. 24(4). e167–e172. 76 indexed citations

Messner, Donna A., et al.. (2018). Paying for Cures: Perspectives on Solutions to the “Affordability Issue”. Value in Health. 21(3). 276–279. 21 indexed citations

Lipman, Paula Darby, et al.. (2017). Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains. Trials. 18(1). 532–532. 23 indexed citations

Messner, Donna A., Robert Cook‐Deegan, Mary A. Majumder, et al.. (2017). Barriers to Clinical Adoption of Next-Generation Sequencing: A Policy Delphi Panel’S Solutions. Personalized Medicine. 14(4). 339–354. 12 indexed citations

10.

Messner, Donna A., et al.. (2016). Understanding practice-based research participation: The differing motivations of engaged vs. non-engaged clinicians in pragmatic clinical trials. Contemporary Clinical Trials Communications. 4. 136–140. 25 indexed citations

11.

Messner, Donna A., Robert Cook‐Deegan, Mary A. Majumder, et al.. (2016). Barriers to clinical adoption of next generation sequencing: Perspectives of a policy Delphi panel. PubMed. 10. 19–24. 31 indexed citations

12.

Tunis, Sean & Donna A. Messner. (2016). Payer Perspectives on Coverage of Biomarker Testing in Cardiovascular Disease. Clinical Chemistry. 63(1). 258–260. 1 indexed citations

13.

Kass, Nancy, Ruth Faden, Rachel Fabi, et al.. (2016). Alternative consent models for comparative effectiveness studies: Views of patients from two institutions. AJOB Empirical Bioethics. 7(2). 92–105. 27 indexed citations

14.

Deverka, Patricia A., Donna A. Messner, Robert McCormack, et al.. (2015). Generating and evaluating evidence of the clinical utility of molecular diagnostic tests in oncology. Genetics in Medicine. 18(8). 780–787. 17 indexed citations

15.

Messner, Donna A., Penny Mohr, & Adrian Towse. (2015). Futurescapes: evidence expectations in the USA for comparative effectiveness research for drugs in 2020. Journal of Comparative Effectiveness Research. 4(4). 385–400. 7 indexed citations

16.

Towse, Adrian, Martina Garau, Penny Mohr, & Donna A. Messner. (2015). Futurescapes: expectations in Europe for relative effectiveness evidence for drugs in 2020. Journal of Comparative Effectiveness Research. 4(4). 401–418. 3 indexed citations

17.

Tunis, Sean & Donna A. Messner. (2013). Medicare Policy on Bariatric Surgery. JAMA. 310(13). 1339–1339. 2 indexed citations

18.

Messner, Donna A. & Sean Tunis. (2012). Current and Future State of FDA-CMS Parallel Reviews. Clinical Pharmacology & Therapeutics. 91(3). 383–385. 9 indexed citations

19.

Gliklich, Richard E, Michelle B Leavy, Priscilla Velentgas, et al.. (2012). Incorporating stakeholder perspectives in developing a translation table framework for comparative effectiveness research. Journal of Comparative Effectiveness Research. 1(3). 281–292. 7 indexed citations

20.

Messner, Donna A.. (2011). Informed choice in direct-to-consumer genetic testing for Alzheimer and other diseases: lessons from two cases. New Genetics and Society. 30(1). 59–72. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact